Entries by

,

BIOTEM implements new industrial unit dedicated to development and production of immunoassays

PRESS RELEASE – June, 20, 2022 – Apprieu (Grenoble) Leader in development of high-quality custom antibodies, BIOTEM is boosting expertise in immunoassays and increasing kit production capacity tenfold   Project partly supported by French government through France Relance economic initiative   Apprieu, near Grenoble, France, June 20, 2022 – BIOTEM, a hybrid Contract Research Organization […]

,

As SYNTHELIS and PEACCEL have signed a strategic partnership to offer their clients a one-stop shop combining Artificial Intelligence (AI) and Cell-Free lead expression for accelerated drug discovery

PRESS RELEASE – 12th April 2022- La Tronche   As of 12th April 2022, PEACCEL and SYNTHELIS combine their know-how and thus capitalize on their respective technologies in developing a joint offer, to respond to the needs of their customers and partners. This joint offer combines the innov’SAR industrial AI platform developed by PEACCEL and […]

,

Microlight 3D releases new range of resins for 3D microprinting

PRESS RELEASE – June 14th- Grenoble Eight new resins widen scope for mechanical meta-materials and life sciences researchers to 3D print, at micro scale, complex objects with novel properties Grenoble, France, June 14, 2022 – Microlight3D, a specialty manufacturer of high-resolution micro-scale 2D & 3D printing systems for industrial and scientific applications, today announces the […]

,

FDA Grants Breakthrough Device Designation to Remedee Labs for its groundbreaking endorphin stimulation solution for the management of Fibromyalgia

Paris – May 12, 2022 – On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough Device Designation to its endorphin stimulator for fibromyalgia patients. The FDA’s Breakthrough Device program exists to accelerate market access for devices that improve care for people with severely debilitating […]

,

CEA: a key player in the field of Organ-on-Chip

On February 23rd  and 24st, 2022, the plenary meeting for the structuring of the OoC sector in France was held in Paris, organized by BioValley France (BVF), Institut Curie/IPGG and the CEA-IRIG (Interdisciplinary Research Institute of Grenoble) (http://irig.cea.fr). This event is a continuation of the digital directory of French experts in Organ-on-Chips (OoC) set up […]

,

EVEON is accelerating its development for the benefit of pharmaceutical companies and patient treatment adherence

Grenoble, March 8, 2022 – EVEON, designer and manufacturer of medical devices for the preparation and delivery of drugs, made numerous project achievements in 2021 in collaboration with pharmaceutical companies. It looks like another promising year ahead for the company as it is carried forward by its dynamism and its innovations for better therapeutic compliance. […]

,

IMABGEN Project, an innovative platform in immunotherapies

Lyon, December 16, 2021 The IMABGEN Platform project, an innovative service for the generation of therapeutic antibodies carried by BIOTEM, CALIXAR and the CNRS / Université Claude Bernard Lyon 1, is one of the laureates of the ‘‘R&D Booster’’ 2021 program driven by the Region Auvergne-Rhône-Alpes. Immunotherapy has become a major approach in the fight […]

,

Microlight3D marks fifth anniversary and reinforces team

Company keeps pace with increased sales and deliveries of new 3D microprinting equipment with recruitment in development, manufacturing and sales Grenoble, France, December 2, 2021 – Microlight3D, a specialty manufacturer of high-resolution micro-scale 2D & 3D printing systems for industrial and scientific applications, today celebrates its fifth anniversary and the arrival of five new team […]

,

ALPAO, selected for the French space recovery plan, as part of a consortium led by Airbus Defence & Space

Grenoble (France) – November 15, 2021 – ALPAO, selected for a prestigious consortium to contribute to the development of the space industry as part of the French recovery plan, is strengthening its leadership position in adaptive optics. One of these collaborative projects aims to structure the French industrial sector for satellite laser communications. The purpose […]

,

NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS

MEYLAN, France, BUBENDORF, Switzerland, (November 3rd, 2021) – NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and Drug Products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials. CARBOGEN […]